Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the gut to treat multiple sclerosis
Laura Ghezzi, Claudia Cantoni, Gabriela Veronica Pinget, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Mendelian randomization analysis reveals causal relationships between gut microbiome and optic neuritis
Kangcheng Liu, Pengfei Wu, Jing Zou, et al.
Human Genetics (2022) Vol. 142, Iss. 8, pp. 1139-1148
Closed Access | Times Cited: 12
The Potential Role of Fecal Microbiota Transplant in the Reversal or Stabilization of Multiple Sclerosis Symptoms: A Literature Review on Efficacy and Safety
Tooba Laeeq, Tahne Vongsavath, Kyaw Min Tun, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2840-2840
Open Access | Times Cited: 6
Probiotics treatment ameliorated mycophenolic acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice
Pengpeng Zhang, Jinwen Chen, Yingzi Ming, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights
Mouhammad Sharifa, Tanmay Ghosh, Omar A Daher, et al.
Cureus (2023)
Open Access | Times Cited: 5
Multiple sclerosis and the microbiota
Hendrik J. Engelenburg, Paul J. Lucassen, Joshua T. Sarafian, et al.
Evolution Medicine and Public Health (2022) Vol. 10, Iss. 1, pp. 277-294
Open Access | Times Cited: 8
The Influence of Intestinal Microbiota on BDNF Levels
Marta Molska, Kinga Mruczyk, Angelika Cisek-Woźniak, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2891-2891
Open Access | Times Cited: 1
Immune mechanisms and shared immune targets in neurodegenerative diseases
Howard L. Weiner
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 1
In-silico characterization of GABAT protein found in gut-brain axis associated bacteria of healthy individuals and multiple sclerosis patients
Nadia Hussain, Fatima Muccee
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 4, pp. 103939-103939
Open Access | Times Cited: 1
Causal Relationship Between Sjögren’s Syndrome and Gut Microbiota: A Two-Sample Mendelian Randomization Study
Xinrun Wang, Minghui Liu, Weiping Xia
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2378-2378
Open Access | Times Cited: 1
Toward Elucidating the Human Gut Microbiota–Brain Axis: Molecules, Biochemistry, and Implications for Health and Diseases
Yunjia Lai, Radhika Dhingra, Zhenfa Zhang, et al.
Biochemistry (2021) Vol. 61, Iss. 24, pp. 2806-2821
Open Access | Times Cited: 10
Implications of immunometabolism for smouldering MS pathology and therapy
Stefan Bittner, Katrin Pape, Luisa Klotz, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 8, pp. 477-488
Closed Access | Times Cited: 3
The characteristics of intestinal microbiota in patients with chronic schistosomiasis japonica-induced liver fibrosis by 16S rRNA gene sequence
Chen Guo, Pengpeng Zhang, Junhui Li, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Down-Syndrome-Related Maternal Dysbiosis Might Be Triggered by Certain Classes of Antibiotics: A New Insight into the Possible Pathomechanisms
Gábor Ternák, Gergely Márovics, Katalin Sümegi, et al.
Antibiotics (2023) Vol. 12, Iss. 6, pp. 1029-1029
Open Access | Times Cited: 2
Probiotic Influences on Motor Skills: A Review
Robert Lalonde, C. Strazielle
Current Neuropharmacology (2023) Vol. 21, Iss. 12, pp. 2481-2486
Open Access | Times Cited: 2
Akkermansia modulates microglia and astrocytes in a strain specific manner
Luke Schwerdtfeger, Toby B. Lanser, Federico Montini, et al.
Research Square (Research Square) (2024)
Open Access
Review of evidence linking exposure to environmental stressors and associated alterations in the dynamics of immunosenescence (ISC) with the global increase in multiple sclerosis (MS)
C. Bolton
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Down-Syndrome Development might be Associated with Dysbiosis, Triggered by Certain Classes of Antibiotics: Altered Maternal Microbiome as a New Insight into the Genomic Events
T. Shane Gabor, Gergely Márovics, Katalin Sümegi, et al.
(2023)
Open Access | Times Cited: 1
From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
Muhammad Faraz Raghib, Evanthia Bernitsas
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3069-3069
Open Access | Times Cited: 1
Dietary Restriction against Parkinson’s Disease: What We Know So Far
Zhonglei Wang, Yueran Cui, Lulu Wen, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 4108-4108
Open Access | Times Cited: 2
Previous Page - Page 2

Scroll to top